MX9203654A - Purificacion, clonacion y caracterizacion del gen para la interleucina i. - Google Patents

Purificacion, clonacion y caracterizacion del gen para la interleucina i.

Info

Publication number
MX9203654A
MX9203654A MX9203654A MX9203654A MX9203654A MX 9203654 A MX9203654 A MX 9203654A MX 9203654 A MX9203654 A MX 9203654A MX 9203654 A MX9203654 A MX 9203654A MX 9203654 A MX9203654 A MX 9203654A
Authority
MX
Mexico
Prior art keywords
new
interleukin
amino acid
cloning vector
gene
Prior art date
Application number
MX9203654A
Other languages
English (en)
Inventor
Douglas Pat Cerretti
Paul Jerome Conlon
David John Cosman
Kenneth Howard Grabstein
Thomas Patrick Hopp
Shirley R Kronneim
Alf D Larsen
Carl Jack March
Virginia Lee Price
Original Assignee
Immunex Corp
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Family has litigation
First worldwide family litigation filed litigation Critical https://patents.darts-ip.com/?family=27542003&utm_source=google_patent&utm_medium=platform_link&utm_campaign=public_patent_search&patent=MX9203654(A) "Global patent litigation dataset” by Darts-ip is licensed under a Creative Commons Attribution 4.0 International License.
Priority claimed from US06/676,533 external-priority patent/US5484887A/en
Application filed by Immunex Corp filed Critical Immunex Corp
Publication of MX9203654A publication Critical patent/MX9203654A/es

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • C07K14/435—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
    • C07K14/52—Cytokines; Lymphokines; Interferons
    • C07K14/54—Interleukins [IL]
    • C07K14/545—IL-1
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P37/00—Drugs for immunological or allergic disorders
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N15/00—Mutation or genetic engineering; DNA or RNA concerning genetic engineering, vectors, e.g. plasmids, or their isolation, preparation or purification; Use of hosts therefor
    • C12N15/09—Recombinant DNA-technology
    • C12N15/63—Introduction of foreign genetic material using vectors; Vectors; Use of hosts therefor; Regulation of expression
    • C12N15/79—Vectors or expression systems specially adapted for eukaryotic hosts
    • C12N15/80—Vectors or expression systems specially adapted for eukaryotic hosts for fungi
    • C12N15/81—Vectors or expression systems specially adapted for eukaryotic hosts for fungi for yeasts

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Engineering & Computer Science (AREA)
  • Genetics & Genomics (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • General Health & Medical Sciences (AREA)
  • Zoology (AREA)
  • Medicinal Chemistry (AREA)
  • Biotechnology (AREA)
  • General Chemical & Material Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Wood Science & Technology (AREA)
  • Biomedical Technology (AREA)
  • General Engineering & Computer Science (AREA)
  • Biochemistry (AREA)
  • Biophysics (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Molecular Biology (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Mycology (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Physics & Mathematics (AREA)
  • Immunology (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Plant Pathology (AREA)
  • Microbiology (AREA)
  • Toxicology (AREA)
  • Peptides Or Proteins (AREA)
  • Preparation Of Compounds By Using Micro-Organisms (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Micro-Organisms Or Cultivation Processes Thereof (AREA)
  • Medicines Containing Material From Animals Or Micro-Organisms (AREA)
  • Saccharide Compounds (AREA)
MX9203654A 1984-06-19 1992-06-26 Purificacion, clonacion y caracterizacion del gen para la interleucina i. MX9203654A (es)

Applications Claiming Priority (5)

Application Number Priority Date Filing Date Title
US62220184A 1984-06-19 1984-06-19
US63500684A 1984-07-27 1984-07-27
US67455584A 1984-11-26 1984-11-26
US06/676,533 US5484887A (en) 1984-06-19 1984-11-30 Homogeneous interleukin 1
US68764684A 1984-12-31 1984-12-31

Publications (1)

Publication Number Publication Date
MX9203654A true MX9203654A (es) 1992-07-01

Family

ID=27542003

Family Applications (1)

Application Number Title Priority Date Filing Date
MX9203654A MX9203654A (es) 1984-06-19 1992-06-26 Purificacion, clonacion y caracterizacion del gen para la interleucina i.

Country Status (10)

Country Link
EP (2) EP0456332B1 (es)
JP (3) JP3217698B2 (es)
AT (2) ATE84547T1 (es)
AU (1) AU579142B2 (es)
CA (2) CA1341433C (es)
DE (2) DE3586972T2 (es)
DK (2) DK168048B1 (es)
IE (1) IE61353B1 (es)
MX (1) MX9203654A (es)
NZ (1) NZ211386A (es)

Families Citing this family (19)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DE3588241T2 (de) * 1984-05-18 2002-12-05 New England Medical Center Inc Menschliche IL-1 cDNS-Sequenzen die für biologisch aktive menschliche IL-1-Proteine kodieren
EP0569687B1 (en) * 1984-05-18 2002-08-21 New England Medical Center Hospitals, Inc. Human IL-1 cDNA sequences encoding biologically-active human IL-1 proteins
US5998578A (en) * 1984-05-18 1999-12-07 New England Medical Center Hospitals, Inc. Biologically active fragments of IL-1β
US6107465A (en) * 1984-12-21 2000-08-22 Otsuka Pharmaceutical Co., Ltd. IL-1β and derivatives thereof and drugs
US5342614A (en) * 1984-12-21 1994-08-30 Otsuka Pharmaceutical Co., Ltd. Method of treating arthritus or inflammation with IL-1β or derivatives thereof
DK172052B1 (da) * 1984-12-21 1997-09-29 Otsuka Pharma Co Ltd Antitumor-aktivt stof, fremgangsmåde til dets fremstilling, lægemiddel indeholdende stoffet, gen kodende for stoffet, vektor indeholdende genet samt rekombinant mikroorganisme transformet med en sådan vektor
EP0188920B1 (en) * 1984-12-25 1993-09-29 Dainippon Pharmaceutical Co., Ltd. Interleukin 1 and its derivative
AU577856B2 (en) * 1985-01-17 1988-10-06 Immunex Corporation Cloning and characterization of the human interleukin 1 gene
DE3683186D1 (de) 1985-04-25 1992-02-13 Hoffmann La Roche Rekombinantes humaninterleukin-1.
US5831022A (en) * 1986-02-18 1998-11-03 Hoffmann-La Roche Inc. Purification of recombinant human IL-1α
US5008374A (en) * 1986-03-14 1991-04-16 Otsuka Pharmaceutical Co., Ltd. IL-1α derivatives and drugs
US4801686A (en) * 1986-09-04 1989-01-31 Immunex Corporation Purification of recombinant interleukin-1
US5047505A (en) * 1987-01-27 1991-09-10 Du Pont Merck Pharmaceutical Company High level expression in E. coli of soluble mature HIL-1beta and derivatives with altered biological activity
US4894333A (en) * 1987-05-28 1990-01-16 Immunex Corporation Bovine interleukin-1α
AU5355790A (en) * 1989-04-19 1990-11-16 Cetus Corporation Multifunctional m-csf proteins and genes encoding therefor
GB9010356D0 (en) * 1990-05-09 1990-06-27 Ciba Geigy Ag Maturation of hemopoietic cells
DE69229252T2 (de) * 1991-08-16 1999-12-16 Merck & Co Inc DNS, welche das Interleukin-1B-Vorläufer-Converting-Enzym kodiert
DE60231845D1 (de) * 2001-12-11 2009-05-14 Univ New Jersey Med Diagnoseverfahren für proteinprofilierung
JP2008543975A (ja) * 2006-08-14 2008-12-04 シコール インコーポレイティド 高度に純粋なペメトレキセド二酸およびその調製方法

Family Cites Families (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DE3378128D1 (en) * 1982-04-20 1988-11-03 Sloan Kettering Inst Cancer Purification of interleukin 2
DE3588241T2 (de) * 1984-05-18 2002-12-05 New England Medical Center Inc Menschliche IL-1 cDNS-Sequenzen die für biologisch aktive menschliche IL-1-Proteine kodieren
DK172052B1 (da) * 1984-12-21 1997-09-29 Otsuka Pharma Co Ltd Antitumor-aktivt stof, fremgangsmåde til dets fremstilling, lægemiddel indeholdende stoffet, gen kodende for stoffet, vektor indeholdende genet samt rekombinant mikroorganisme transformet med en sådan vektor
AU577856B2 (en) * 1985-01-17 1988-10-06 Immunex Corporation Cloning and characterization of the human interleukin 1 gene

Also Published As

Publication number Publication date
DE3586972T2 (de) 1993-07-08
AU579142B2 (en) 1988-11-17
EP0456332B1 (en) 2000-08-09
EP0165654A2 (en) 1985-12-27
ATE84547T1 (de) 1993-01-15
NZ211386A (en) 1989-04-26
CA1340978C (en) 2000-05-02
DE3588224D1 (de) 2000-09-14
EP0165654A3 (en) 1988-05-04
DK168048B1 (da) 1994-01-24
DK110485D0 (da) 1985-03-11
JPH09118697A (ja) 1997-05-06
DE3586972D1 (de) 1993-02-25
IE850614L (en) 1986-09-08
AU3986385A (en) 1986-01-02
IE61353B1 (en) 1994-11-02
EP0456332A1 (en) 1991-11-13
EP0165654B1 (en) 1993-01-13
ATE195344T1 (de) 2000-08-15
JP2000060577A (ja) 2000-02-29
JP3217698B2 (ja) 2001-10-09
DK110485A (da) 1985-12-20
DK37293D0 (da) 1993-03-30
CA1341433C (en) 2003-06-24
JPH10279598A (ja) 1998-10-20
JP3009381B2 (ja) 2000-02-14
DK37293A (da) 1993-03-30
DE3588224T2 (de) 2001-10-25

Similar Documents

Publication Publication Date Title
MX9203654A (es) Purificacion, clonacion y caracterizacion del gen para la interleucina i.
Allen et al. A family of structural genes for human lymphoblastoid (leukocyte-type) interferon
KR890003802A (ko) 재조합 dna 기술에 의해 제조된 소의 췌장 트립신 억제제, 그 제조 방법, 발현 벡터 및 재조합 숙주 및 그의 제약적 용도
CA2067744A1 (en) The human c3b/c4b receptor (cr1)
NL300013I1 (nl) Nieuwe protein met TNF-remmende werking en hun ber
ZA907693B (en) The human c3b/c4b receptor(cr1)
DK165988B (da) Modificerede egliner b og c, deres anvendelse som proteaseinhibitorer, fremgangsmaade til fremstilling deraf samt farmaceutiske praeparater indeholdende de modificerede egliner b og c
KR880009125A (ko) 재조합 숙주에 의해 제조되는 췌장분비 트립신 억제제 및 그의 변이체, 그의 방법, 표현벡터 및 재조합 숙주 및 그의 제약상 용도
Schmelzer et al. Biochemical characterization of recombinant human nerve growth factor
Klippenstein et al. The primary structure of myohemerythrin
KR940005798A (ko) 지방세포화 억제 인자 유도체, 그의 제조방법 및 용도
DE59109085D1 (de) Epididymis-spezifische Polypeptide und deren Verwendung
Ueno et al. Purification and partial characterization of a mitogenic factor from bovine liver: structural homology with basic fibroblast growth factor
Francis et al. Carboxyl-terminal amino acid sequences of two variant forms of the gamma chain of human plasma fibrinogen.
CA2072587A1 (en) Oxidized variants of gm-csf
Lauren et al. Covalent dimerization of recombinant human interferon-γ
Aggarwal et al. [34] Human tumor necrosis factor
MARDER Carboxyl-terminal amino acid sequences of two variant forms of the y chain of human plasma fibrinogen
DK200200302A (da) Rekombinante polypeptider omfattende aminosyresekvensen af moden vævsfaktorinhibitor (TFI), polypeptidfragmenter deraf, ekspressionsvektorer der koder for disse, værtsceller transformeret dermed, og fremgangsmåde til fremstilling af et ........
Tsuji et al. Structural and biological identity of recombinant EDF (erythroid differentiation factor) with natural EDF
Song Purification and characterization of papaya latex glutaminyl cyclase and molecular cloning, sequence analysis, and expression of human pituitary glutaminyl cyclase.
TH1778EX (th) สารคล้ายคลึง จี อาร์ เอฟ (grf)
TH12889A (th) เคอร์คูลิน บี และคีเอ็นเอที่เป็นรหัสของสารดังกล่าว และขบวนการสำหรับการผลิตสารดังกล่าว